Modifying dolutegravir to PrEPare to prolong life
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License. It allows you to use, share, adapt, distribute, and reproduce this article in any medium or format as long as you credit the original author(s), the source, provide a link back to the Creative Commons license, indicate if any changes were made, and give appropriate credit to the source. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Reprints and Permissions
